Benzinga | Dec 2, 2020 05:53AM EST

JMP Securities Downgrades Ovid Therapeutics to Market Perform

JMP Securities analyst Jason Butler downgrades Ovid Therapeutics (NASDAQ:OVID) from Market Outperform to Market Perform.